Article

Eye center opens in Indonesia

The first ophthalmology training center developed as part of an effort to eliminate preventable blindness in the world by 2020 has opened at Cicendo Hospital, Bandung, Indonesia.

Bandung, Indonesia-The first ophthalmology training center developed as part of an effort to eliminate preventable blindness in the world by 2020 has opened at Cicendo Hospital, Bandung, Indonesia.

Michael Kaschke, MD, director of Carl Zeiss AG and chairman of the supervisory board of Carl Zeiss Meditec AG, and Gullapalli N. Rao, MD, president of the International Agency for the Prevention of Blindness, officially opened the facility last month as part of the Vision 2020 initiative.

The ophthalmology center is funded in part by a $200,000 donation from Carl Zeiss. The money will be used to train staff and provide equipment. The company also donated several systems for diagnosis, treatment, and aftercare, including slit lamps, treatment lasers, and a surgical microscope.

Blindness remains a major problem in Indonesia, where the rates have increased from 1.2% in 1978 to 1.5% in 1996. The main cause of blindness is cataracts, which afflicts 1.4 million Indonesians.

Carl Zeiss has committed to supporting the launches of four additional training centers within the next 5 years.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.